by Danielle Bonadies | Feb 6, 2020 | News
Paired tumor/germline testing is far from standard practice in cancer care, but some experts in the field are advocating that when patients have their tumors genomically profiled to determine precision medicine options, that is an opportunity to also evaluate them for...
by Danielle Bonadies | Jan 2, 2020 | News
In 2019, the field of personalized medicine continued to grow with the market launch of more than two dozen drugs targeting novel genomic alterations and numerous genetic tests to determine whether patients are at risk for serious diseases like cancer, and whether...
by Danielle Bonadies | Oct 16, 2019 | Press Releases
Genomic updates are critical to harness the power of precision medicine NEW HAVEN, CONN. (PRWEB) OCTOBER 16, 2019 My Gene Counsel, a digital health company that provides personalized, easy-to-understand, web-based genetic counseling information, has published a...
by Danielle Bonadies | Sep 12, 2019 | News
Investigators at Ambry Genetics, the Mayo Clinic in Rochester, the University of Utah, and the University of California at Irvine have tapped into Ambry’s large collection of multigene panel test results to clarify hereditary cancer associations in high-risk...
